The focus of Enzymicals
is the development, production and utilisation of innovative biocatalysts. We cover the entire value chain from bio- catalyst discovery via their optimisation by protein engineering tools to the efficient application in biocatalysis. This includes the development of economic processes as well as the production of high value building blocks and chemicals using tailor-made processes.
The main focus herein is the industrial application of biocatalytic syntheses for a resource friendly chemistry.

August 8th 2011
Enzymicals will be present at the Biotechnica (October 11th-13th in Hanover, Germany) in hall 9, stand E40. We will also give a presentation within the "Forum Industrielle Biotechnologie".
Moreover, we will attend CPhI Worldwide (October 25th-27th in Frankfurt/M., Germany) where we will be available for talks.

April 4th 2011
Due to company growth Enzymicals moved into new premises, expanding the lab space to 145 m² and improving efficiency.

October 4th 2010
Enzymicals AG acquires proprietary rights on pig liver esterases (PLE) from Evonik AG.
Press Releases

July 12th 2010
BRAIN AG acquires share in chemical and biocatalyst specialist Enzymicals AG.
Press Releases

August 27th 2009
Enzymicals AG is founded.